Companies / Maryland / Shuttle Pharmaceuticals

· rebuilt nightly from public records

Signal Sheet

Selling to Shuttle Pharmaceuticals? Who to reach and why now

Gaithersburg, Maryland is home to Shuttle Pharmaceuticals, a publicly listed pharmaceutical preparations company. It raised $10M in Apr 2026 and its filings name 15 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Maryland

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerChristopher CooperSEC filing, Apr 2026Named officer in the filing; part of the buying group
Executive OfficerYuying LiangSEC filing, Apr 2026Named officer in the filing; part of the buying group
Executive OfficerRyan TrasoliniSEC filing, Apr 2026Named officer in the filing; part of the buying group
Executive OfficerTimothy LorberSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerTyvin RichSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerMira JungSEC filing, Nov 2025Named officer in the filing; part of the buying group
Executive OfficerPeter DritschiloSEC filing, Jun 2025Named officer in the filing; part of the buying group
Chief Technology OfficerGeorge ScorsisSEC filing, Apr 2026Technology and tooling decisions
Chief Technology OfficerAdam ChambersSEC filing, Apr 2026Technology and tooling decisions
Chief Technology OfficerAngel LirianoSEC filing, Apr 2026Technology and tooling decisions
Chief Technology OfficerOleh NabytSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerSachin PathigodaSEC filing, Nov 2025Technology and tooling decisions
Chief Technology OfficerGeorge ScorcisSEC filing, Jun 2025Technology and tooling decisions
Chief Technology OfficerSteven RichardsSEC filing, Jun 2025Technology and tooling decisions
Chief Technology OfficerJoseph TungSEC filing, Jun 2025Technology and tooling decisions
For sellersWhy Shuttle Pharmaceuticals is worth a call this quarterBuy Window: open · major agreement Aug 2026
Aug 2026Aug 2026

Corporate event

Signed a material agreement

Corporate event
$10M

Raised

Equity raise reported to the SEC, Apr 2026. Money arrives before the spending plan does.

Capital
$16.7M10 months

Back-to-back raises

3 equity raises in 10 months. Repeat funding is a company buying for growth, not maintenance.

Pattern
Track Shuttle Pharmaceuticals with a free trial →Get the next signal the day it is filed or posted.
Email me the next Shuttle Pharmaceuticals signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Aug 31, 2026Signed a material agreementCorporate eventSEC filing
May 1, 2026Completed an acquisition or saleCorporate eventSEC filing
Apr 30, 2026Raised $10M in equity from 47 investorsCapitalSEC filing
Nov 3, 2025Raised $2.5M in equity from 1 investorsCapitalSEC filing
Jun 20, 2025Raised $4.2M in equity from 1 investorsCapitalSEC filing

Reach Shuttle Pharmaceuticals with emails that land

Lakewave finds the right people at Shuttle Pharmaceuticals, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Shuttle Pharmaceuticals with a free trial →

About Shuttle Pharmaceuticals

HeadquartersGaithersburg, Maryland, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$4.2M (Jun 2025) · $2.5M (Nov 2025) · $10M (Apr 2026)
Lakewave Rising5 · 2 kinds of evidence · rank in Maryland after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Theriva Biologics · 28NextCure · 15Emergent Biosolutions · 10United TherapeuticsSee all 4 with a free trial →

Questions people ask

Did Shuttle Pharmaceuticals raise funding in 2026?

Yes. Shuttle Pharmaceuticals reported a $10M equity raise to the SEC on Apr 30, 2026 with 47 investors.

Who runs Shuttle Pharmaceuticals?

The company's SEC filing, Apr 2026 names Christopher Cooper (Executive Officer) among its officers.

Where is Shuttle Pharmaceuticals headquartered?

Gaithersburg, Maryland, per the address on its SEC filing.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.